{{Rsnum
|rsid=4253623
|Gene=PPARA
|Chromosome=22
|position=46154203
|Orientation=plus
|GMAF=0.1097
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PPARA
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 74.3 | 24.8 | 0.9
| HCB | 75.2 | 22.6 | 2.2
| JPT | 77.0 | 22.1 | 0.9
| YRI | 91.8 | 8.2 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 75.2 | 22.6 | 2.2
| CHD | 78.9 | 20.2 | 0.9
| GIH | 67.3 | 30.7 | 2.0
| LWK | 98.2 | 1.8 | 0.0
| MEX | 70.7 | 25.9 | 3.4
| MKK | 98.1 | 1.9 | 0.0
| TSI | 78.4 | 17.6 | 3.9
| HapMapRevision=28
}}
[[rs4253623]](G) alleles are associated with a slightly higher risk of nonfatal [[myocardial infarction]] (odds ratio 1.25, CI: 1.08 - 1.46) in 848 patients composed of both postmenopausal women and hypertensive men/women.{{PMID|18549840|OA=1
}}

{{PMID Auto
|PMID=18586686
|Title=Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary study.
|OA=1
}}

{{PMID Auto
|PMID=20426853
|Title=Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}